Altre lingue Ascendis Pharma A/S

Azioni

ASND

US04351P1012

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 18/04/2024			Variaz. 5gg	Var. 1 gen.
140,9 ^USD	-0,90%		-6,72%	+11,86%

18/04	Le azioni europee scambiate negli Stati Uniti, mentre le ricevute americane di deposito sono rimaste ferme nelle contrattazioni del giovedì	MT
02/04	ASCENDIS PHARMA A/S : da JPMorgan Chase è Buy	ZM

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading	18/04
Ascendis Pharma A/S : Form 6-K	10/04
European Equities Traded in the US as American Depositary Receipts Slightly Higher Thursday	28/03
Ascendis Pharma A/S : Form 6-K	27/03
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	21/03
Ascendis Pharma A/S : Form 6-K	14/03
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading	13/03
European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading	12/03
Ascendis Pharma to Participate in the Leerink Partners Global Biopharma Conference 2024	04/03
Ascendis Pharma A/S Appoints Mads Bodenhoff as Senior Vice President, Finance Principal Accounting Officer	29/02
European Equities Traded in the US as American Depositary Receipts Set to End Week Higher in Friday Trading	16/02
European Equities Traded in US as American Depositary Receipts Move Slightly Higher in Friday Trading	09/02
Ascendis Pharma Q4 Net Loss Narrows, Revenue Rises	07/02
Earnings Flash (ASND) ASCENDIS PHARMA Posts Q4 Revenue EUR137.7M	07/02
Ascendis Pharma Reports Fourth Quarter and Full Year 2023 Results	07/02
Ascendis Pharma A/S Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	07/02
Ascendis Pharma A/S Reports Earnings Results for the Full Year Ended December 31, 2023	07/02
Ascendis Pharma to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference	07/02
European Equities Traded in the US as American Depositary Receipts Make Modest Gains in Thursday Trading	01/02
Ascendis Pharma to Report Full Year 2023 Financial Results and Provide Business Update on February 7, 2024	31/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Ascendis Pharma A/S

Azioni

ASND

US04351P1012

Altre lingue

Filtri